Keratoconus is a progressive eye condition that affects the cornea, causing it to thin and bulge into a cone-like shape. This deformation can lead to significant visual impairment and is often challenging to manage with traditional corrective measures such as glasses or contact lenses. One of the most promising keratoconus treatment options is UV crosslinking, a procedure designed to strengthen the corneal tissue and halt the progression of the disease. In this blog, we will explore what UV crosslinking is, how it benefits keratoconus patients, and why it is a crucial option for those suffering from this condition.
What is UV Crosslinking?
UV crosslinking, also known as corneal collagen crosslinking (CXL), is a minimally invasive procedure that involves the application of riboflavin (vitamin B2) to the cornea, followed by controlled exposure to ultraviolet (UV) light. This combination induces the formation of new bonds (crosslinks) between collagen fibers in the cornea, thereby increasing its strength and rigidity.
How Does UV Crosslinking Work?
The UV crosslinking procedure typically follows these steps: